About Lee Biosolutions
Lee Biosolutions is a Healthcare company based in Maryland Heights (United States) founded in 1975, and was acquired by Medix Biochemica in October 2019. Lifescience reagents are manufactured for clinical diagnostic tests. Lee Biosolutions has completed 1 acquisition, including Creative Laboratory Products. Lee Biosolutions offers products and services including Antigens, Enzymes, Antibodies, and Biologicals. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics. Its legal entity is LEE BIOSOLUTIONS, INC. Its competitors include PrognomiQ, ACRO Biosystems and Ansh Labs; 1 of its 3 listed competitors has raised funding.
Company details
Lee Biosolutions is a biotechnology company engaged in the custom and bulk manufacturing and preparation of a variety of reagents such as enzymes, antibodies, and biological samples and specimens used in clinical diagnostic tests for pathologies such as cardiac disease, cancer, diabetes, urine analysis, obesity, inflammation, neurological, autoimmune diseases, immunological disorders. In addition, the company offers a range of services including GMPOEM production and custom purification, Product assay development, Process validation optimization, Analytical testing Technical support. The company acquired the Indiana-based producer of human and animal cholesterol concentrates company, Creative Laboratory Products, Inc, on March 14th, 2016.
- Headquarters Maryland Heights, United States
- Stage Acquired
- SectorsHealthcare
- Phone•••• ••••
- Website leebio.com
- Social LinkedIn X Facebook YouTube
- Acquired by Medix Biochemica (Oct 2019)
- Legal Name Lee Biosolutions, Inc.
- Investors
- Investments & Acquisitions
- Acquired byMedix Biochemica
(Oct 2019)
Products & Services of Lee Biosolutions
Lee Biosolutions offers a comprehensive portfolio of products and services, including Antigens, Enzymes, Antibodies, and Biologicals.
High-purity antigens for diagnostic and research use
Purified enzymes for life science applications
Affinity purified antibodies for assays and testing
Human and animal samples for research development
Apps and channels of Lee Biosolutions
its YouTube channel Medix Biochemica has 67 subscribers and 19 videos.
Videos from Lee Biosolutions
The most watched videos on Lee Biosolutions's YouTube channel, Medix Biochemica (67 subscribers). Click a video to play it here.
More on Medix Biochemica.
Investors in Lee Biosolutions
Lee Biosolutions has secured backing from 1 investor. Prominent investors backing the company include Medix Biochemica.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Develops and markets rapid diagnostic tests and bioreagents | 1985 | medixbiochemica.com | Espoo, Finland |
Investor details for Lee Biosolutions
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lee Biosolutions
Lee Biosolutions has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Creative Laboratory Products.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Bio reagents including cholesterol concentrates are produced for diagnostics. | clplipids.com | Indianapolis, United States | 1987 | Mar 2016 | •••• |
Complete acquisition details for Lee Biosolutions
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Lee Biosolutions
3 dated milestones of Lee Biosolutions across 44 years, from founding to its latest funding, stage changes and deals.
- Founded Lee Biosolutions is founded.
- Acquisition Acquires Creative Laboratory Products.
- Exit Acquired by Medix Biochemica.
Competitors of Lee Biosolutions
Lee Biosolutions has 3 listed competitors in our database, 1 of them funded. They include PrognomiQ, ACRO Biosystems and Ansh Labs.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| prognomiq.com | 2020 | San Mateo, United States | $90.36M | 24 | Developer of tests for the detection and treatment of cancer and other diseases | |
| acrobiosystems.com | 2016 | Newark, United States | 22 | Recombinant proteins are manufactured to support cancer immunotherapy efforts. | ||
| anshlabs.com | 2010 | Webster, United States | 33 | Immunoassay reagents and kits are developed for life science research. |
Detailed competitors of Lee Biosolutions
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Lee Biosolutions
The website of Lee Biosolutions (leebio.com) receives about 4.7K visits a month.
- Monthly visits4.7K
▼ 44.6% vs previous month
Websites whose visitors overlap most with Lee Biosolutions. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
urinetheclear.com | urinetheclear.com | 100% | #6,875,873 | – | |
| ferm-solutions.net | 99% | #4,367,675 | View details | ||
bsghandcraft.com | bsghandcraft.com | 96% | #3,689,706 | – | |
brewhaus.com | brewhaus.com | 86% | #1,650,564 | – |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Lee Biosolutions (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lee Biosolutions
Lee Biosolutions was founded in 1975.
Lee Biosolutions is headquartered in Maryland Heights, United States. It is registered at Maryland Heights, Missouri, United States.
Lee Biosolutions is a biotechnology company engaged in the custom and bulk manufacturing and preparation of a variety of reagents such as enzymes, antibodies, and biological samples and specimens used in clinical diagnostic tests for pathologies such as cardiac disease, cancer, diabetes, urine analysis, obesity, inflammation, neurological, autoimmune diseases, immunological disorders. In addition, the company offers a range of services including GMPOEM production and custom purification, Product assay development, Process validation optimization, Analytical testing Technical support. The company acquired the Indiana-based producer of human and animal cholesterol concentrates company, Creative Laboratory Products, Inc, on March 14th, 2016.
Lee Biosolutions's top competitors include PrognomiQ, ACRO Biosystems and Ansh Labs.
Lee Biosolutions offers Antigens, Enzymes, Antibodies, and Biologicals.
Lee Biosolutions has made 1 acquisition, including Creative Laboratory Products.
Lee Biosolutions has 1 investor. Key investors include Medix Biochemica.
Lee Biosolutions operates through Lee Biosolutions, Inc..
Yes. Lee Biosolutions was acquired by Medix Biochemica in October 2019.